PHARMACRYST Trademark

Trademark Overview

On Tuesday, December 27, 2005, a trademark application was filed for PHARMACRYST with the United States Patent and Trademark Office. The USPTO has given the PHARMACRYST trademark a serial number of 78780818. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, January 30, 2012. This trademark is owned by Nucryst Pharmaceuticals Corp.. The PHARMACRYST trademark is filed in the Pharmaceutical Products category with the following description:

Dermatological creams, gels, foams, ointments and/or solutions; respiratory products, namely, nebulizer solutions, dry powder for inhalers and metered dose inhalers; gastrointestinal products, namely, enemas, suppositories, and oral medication
pharmacryst

General Information

Serial Number78780818
Word MarkPHARMACRYST
Filing DateTuesday, December 27, 2005
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, January 30, 2012
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 3, 2011

Trademark Statements

Goods and ServicesDermatological creams, gels, foams, ointments and/or solutions; respiratory products, namely, nebulizer solutions, dry powder for inhalers and metered dose inhalers; gastrointestinal products, namely, enemas, suppositories, and oral medication

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, January 4, 2006
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameSMITH & NEPHEW (OVERSEAS) LIMITED
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressLONDON WC2N 6LA
GB
Party NameSMITH & NEPHEW (OVERSEAS) LIMITED
Party Type11 - New Owner Before Publication
Legal Entity Type16 - Limited Liability Company
AddressLONDON WC2N 6LA
GB
Party NameNucryst Pharmaceuticals Corp.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFort Saskatchewan, Alberta T8L 3W4
CA

Trademark Events

Event DateEvent Description
Monday, January 30, 2012ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, January 30, 2012ABANDONMENT - NO USE STATEMENT FILED
Tuesday, June 28, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 3, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 3, 2011PUBLISHED FOR OPPOSITION
Saturday, March 26, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Saturday, March 26, 2011ASSIGNED TO LIE
Thursday, March 10, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 1, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 28, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 28, 2011TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Wednesday, October 13, 2010ASSIGNED TO EXAMINER
Thursday, August 26, 2010TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 26, 2010NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 26, 2010INQUIRY TO SUSPENSION E-MAILED
Thursday, August 26, 2010SUSPENSION INQUIRY WRITTEN
Friday, February 26, 2010ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 26, 2010TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 26, 2010NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 26, 2010LETTER OF SUSPENSION E-MAILED
Friday, February 26, 2010SUSPENSION LETTER WRITTEN
Wednesday, February 3, 2010AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, January 4, 2010ASSIGNED TO EXAMINER
Thursday, August 27, 2009NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 27, 2009INQUIRY TO SUSPENSION E-MAILED
Thursday, August 27, 2009SUSPENSION INQUIRY WRITTEN
Thursday, August 27, 2009LIE CHECKED SUSP - TO ATTY FOR ACTION
Friday, February 27, 2009NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, February 27, 2009LETTER OF SUSPENSION E-MAILED
Friday, February 27, 2009SUSPENSION LETTER WRITTEN
Friday, February 27, 2009TEAS/EMAIL CORRESPONDENCE ENTERED
Friday, February 27, 2009CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 26, 2009TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 26, 2009PETITION TO REVIVE-GRANTED
Thursday, February 26, 2009TEAS PETITION TO REVIVE RECEIVED
Thursday, February 12, 2009ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
Thursday, February 12, 2009ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Thursday, July 17, 2008NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, July 17, 2008INQUIRY TO SUSPENSION E-MAILED
Thursday, July 17, 2008SUSPENSION INQUIRY WRITTEN
Wednesday, January 16, 2008NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Wednesday, January 16, 2008LETTER OF SUSPENSION E-MAILED
Wednesday, January 16, 2008SUSPENSION LETTER WRITTEN
Wednesday, January 16, 2008AMENDMENT FROM APPLICANT ENTERED
Wednesday, January 16, 2008CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, January 14, 2008ASSIGNED TO LIE
Thursday, January 10, 2008PAPER RECEIVED
Monday, July 16, 2007NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Monday, July 16, 2007INQUIRY TO SUSPENSION E-MAILED
Monday, July 16, 2007SUSPENSION INQUIRY WRITTEN
Tuesday, January 16, 2007LETTER OF SUSPENSION E-MAILED
Tuesday, January 16, 2007SUSPENSION LETTER WRITTEN
Tuesday, January 16, 2007AMENDMENT FROM APPLICANT ENTERED
Tuesday, January 16, 2007CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 16, 2007ASSIGNED TO LIE
Tuesday, December 12, 2006PAPER RECEIVED
Thursday, June 22, 2006NON-FINAL ACTION E-MAILED
Thursday, June 22, 2006NON-FINAL ACTION WRITTEN
Thursday, June 22, 2006ASSIGNED TO EXAMINER
Wednesday, January 4, 2006NEW APPLICATION ENTERED IN TRAM

Related Keywords

pharmacryst products namely inhalers solutions dose metered medication oral suppositories gastrointestinal